People living with severe asthma have been overlooked and underserved for too long. Timely, equitable and high-quality care for this condition needs to be an integral part of every health system.
Yang Xu, Director of Medical Affairs for Respiratory & Immunology at AstraZeneca UK, explores whether the UK over-relies on SABA inhalers, and how we can do better to improve asthma care and treatment.
Read this article to learn about normal changes to the respiratory and urinary systems during pregnancy, along with associated common pathologies and complications